Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Costin

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Lancet (London, England)|May 19, 1990
Poliomyelitis outbreak in Israel in 1988: a report with two commentariesP E Slater, W A Orenstein, A Morag, et al.
The New England Journal of Medicine|November 6, 2014
Use of PER977 to reverse the anticoagulant effect of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Thrombosis and Haemostasis|November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Lancet (London, England)|May 19, 1990
Poliomyelitis outbreak in Israel in 1988: a report with two commentariesP E Slater, W A Orenstein, A Morag, et al.
The New England Journal of Medicine|November 6, 2014
Use of PER977 to reverse the anticoagulant effect of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Thrombosis and Haemostasis|November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxabanJack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Pageof 6